American Association for Cancer Research

Skip to Main Content

Table 2

Skp2 expression in relation to age, clinical stage, histological type, and histological grade in ovarian adenocarcinomas

	N	Skp2-positive expression (%)^a
Adenocarcinoma	91	43 (47.3)
Age (yr)
<50	41	16 (39.0)
>51	50	27 (54.0)
Clinical stage
Stage I	34	10 (29.4)^b
Stage II/III/IV	57	33 (57.9)^b
Histological type
Serous	39	23 (59.0)^c
Mucinous	19	5 (26.3)^c
Endometrioid	18	8 (44.4)
Clear cell	15	7 (46.7)
Histological grade
Grade 1	56	27 (48.2)
Grade 2/3	35	16 (45.7)

	N	Skp2-positive expression (%)^a
Adenocarcinoma	91	43 (47.3)
Age (yr)
<50	41	16 (39.0)
>51	50	27 (54.0)
Clinical stage
Stage I	34	10 (29.4)^b
Stage II/III/IV	57	33 (57.9)^b
Histological type
Serous	39	23 (59.0)^c
Mucinous	19	5 (26.3)^c
Endometrioid	18	8 (44.4)
Clear cell	15	7 (46.7)
Histological grade
Grade 1	56	27 (48.2)
Grade 2/3	35	16 (45.7)

^a

Skp2 expression positive, more than 5% positive tumor cell staining including partial positive and diffuse positive.

^b

Significant; stage I versus stage II/III/IV: P = 0.010 (Fisher’s exact test).

^c

Significant; serous versus mucinous adenocarcinoma: P = 0.019 (Fisher’s exact test).